Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. FE [Internet]. 2014 Dec. 22 [cited 2025 Jul. 23];15(4):101-12. Available from: https://provafe.seedstm.com/index.php/FE/article/view/971